Iceland· IS-EU/1/12/790/001-008
Tovanor Breezhaler
A glycopyrronium bromid product containing glycopyrronii bromidum inn, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium bromid is registered in 12 of 19 countries.
Countries holding a registration under ATC R03BB06 (glycopyrronium bromid), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Glycopyrronium bromid · ATC R03BB06
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of glycopyrronium bromid costs, country by country.
Normalised to the WHO defined daily dose (44 mcg), the median price runs from $0.95 in Italy to $1.46 in Switzerland — a ×1.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Glycopyrronium bromid · price per daily dose (44 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$1.46
- IT Italy$0.95
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Glycopyrronii bromidum INN
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- R03BB06
- ATC class
- Glycopyrronium bromid
- Defined daily dose
- 44 mcg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
213 interactions on record for glycopyrronium bromid.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glycopyrronium bromid · interactions on record
213 records
- 6 severe
- 190 moderate
- 17 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glycopyrronium bromid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAxhidrox 8 mg/g, crèmeEuro Registratie Collectief B.V.
- PolandAMIDIL AmiHalerZakłady Farmaceutyczne POLPHARMA S.A.
- ItalyGLICOPIRRONIO DOCDOC GENERICI S.R.L.
- SpainAXHIDROX 2,2 MG/PULSACION CREMAIndustrial Farmaceutica Cantabria S.A.
- SwitzerlandAxhidrox 2,2 mg/Hub, CremeGebro Pharma AG
- United StatesQbrexzaJourney Medical Corporation
- GermanyRybrilaColonis Pharma B.V.
- DenmarkEnurev BreezhalerNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Rybrila
- Germany · Rybrila
- Spain · Axhidrox
- Sweden · Glycopyrronium Cantabria
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebfdf8e3-22f5-4394-b8a0-55cadd2fd30f GET /v1/drugs/ebfdf8e3-22f5-4394-b8a0-55cadd2fd30f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innöndunarduft, hart hylki",
"source": "lyfjastofnun",
"atc_raw": "R03BB06",
"marketed": false,
"strength": "50 míkróg",
"ma_number": "EU/1/12/790/001-008",
"substance": "Glycopyrronii bromidum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41180"
}See everything about glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.